Compound 1079
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)[n+]1[O-]
- IUPAC name:
3,5-dichloro-N-[[6-[[(3,5-dichlorophenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-1-oxidopyridin-1-ium-2-yl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide
- InChi:
InChI=1S/C33H25Cl4F2N3O6S2/c34-23-12-24(35)14-30(13-23)49(45,46)40(17-21-4-8-26(38)9-5-21)19-28-2-1-3-29(42(28)44)20-41(18-22-6-10-27(39)11-7-22)50(47,48)32-16-25(36)15-31(37)33(32)43/h1-16,43H,17-20H2
- InChiKey:
NWRBQVUBOTZGSE-UHFFFAOYSA-N
External links
![]() 44517707 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 92 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.34 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 800.99 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 7.77 | |||
TPSA | 120.45 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 92 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.34 | |
WO2009152082 | 92 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.22 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4595 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4389 | Omidenepag isopropyl | DB15071 | |
0.4372 | Evatanepag | DB12022 | |
0.4114 | PBT-1033 | DB05565 | |
0.4039 | CGS-27023 | DB07556 | |
0.4030 | Taprenepag | DB12623 | |
0.4000 | 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide | DB08211 | |
0.4000 | Sulfabenzamide | DB09355 | |
0.3990 | LY-295501 | DB12574 | |
0.3945 | Avagacestat | DB11893 | |
0.3897 | Fenquizone | DB13708 | |
0.3897 | WAY-151693 | DB02071 | |
0.3869 | Elubrixin | DB12135 | |
0.3846 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3839 | (2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE | DB07568 |